Enter your login e-mail to the account
Search
Search parameters
Search results
- The role of targeted therapy in the treatment of renal cell carcinoma
doc. MUDr. Jozef Mardiak, CSc.
(11/2009, Review articles ) - Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles ) - NOVINKY VO FARMAKOTERAPII: KATEGORIZÁCIA OD 1. JANUÁRA 2009
Ing. Mgr. Dagmar Hroncová
(11/2008, Informations )
- Správa zo 17. celoštátnej pracovnej konferencie SEKCAMA konanej v dňoch 17. a 18. mája 2012
doc. MUDr. Vladimír Bella, PhD.
(4/2012, Events ) - Milí čitatelia! - úvodné slovo
prof. MUDr. Stanislav Špánik, CSc.
(1/2011, Editorial ) - Biologic and targeted therapy for urogenital maliginities
MUDr. Mária Rečková
(1/2011, Review articles ) - Waldenström’s macroglobulinemia in 2016: in order to optimize immunochemotherapy minimizing side effects
MUDr. Michal Kaščák, Mgr. Zuzaná Kufová, Mgr. Kateřina Growková, prof. MUDr. Roman Hájek, CSc.
(5/2016, Spectrum ) - Správa z X. Košických chemoterapeutických dní, 23. – 24. november 2006
MUDr. Radovan Barilla
(1/2007, Events ) - Novinky z ASCO 2006
MUDr. Tomáš Šálek, MUDr. Radovan Barilla,
(3/2006, Events ) - mTOR inhibitors in the treatment of advanced renal cell carcinoma
MUDr. Radovan Barilla, PhD., MUDr. Zuzana Syčová-Milá
(1/2009, Review articles ) - Future of treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2013, Focus ) - Novinky z výročního setkání Americké společnosti klinické onkologie
MUDr. Jan Novotný, PhD.
(4/2007, Events ) - Publikujeme v zahraničí
(6/2013, Information & comments ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - Patient registries – a need for real data in the context of efficacy, safety and cost effectiveness
PharmDr. Dominik Tomek, MPH, RNDr. Mária Pšenková, Ing. Branislav Balvan
(2/2010, Review articles ) - Pneumotoxicity of molecularly targeted anticancer drugs
doc. MUDr. Peter Beržinec, CSc.
(1/2013, Main topic ) - Health technology assessment and value for money in drug policy
PharmDr. Martin Višňanský, MBA, PhD., MSc., Mgr. Radoslav Suchovič
(2/2017, Main topic ) - Metronomic chemotherapy – promising therapeutical approach for recurrent/ refractory high risk tumours in children
MUDr. Irina Oravkinová, MUDr. Ladislav Deák, MUDr. Jaroslava Feketeová, MUDr. Viktória Halušková, MUDr. Ivana Senčáková, MUDr. Igor Jenčo
(5/2011, Original articles & case reports ) - Systemic treatment of bladder cancer – neoadjuvant, adjuvant and palliative chemotherapy
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Peter Kohútek, MUDr. Tomáš Sedláček
(3/2016, Review articles ) - Selected drug interactions in oncology
MUDr. Veronika Ballová, MUDr. Ján Rajec, PhD.
(5/2011, Review articles ) - Chemotherapy of Tumours of CNS
MUDr. Peter Kalina, CSc.
(3/2010, Review articles ) - The present approach to treatment of renall cell carcinoma
MUDr. Zuzana Syčová-Milá
(5/2010, Review articles ) - New mechanism of action in the treatment of renal cell carcinoma: m-TOR – a novel target
MUDr. Hana Študentová, prof. MUDr. Bohuslav Melichar, Ph.D.
(5/2010, Review articles ) - First line treatment of metastatic renal cell cancer in 2014
MUDr. Mária Rečková
(4/2014, Main topic ) - Treatment of metastatic clear cell renal cell carcinoma after failure of first-line treatment
MUDr. Marián Streško, PhD.
(4/2014, Main topic ) - ESMO KONGRES, 12. – 16. 9. 2008, ŠTOKHOLM
MUDr. Marián Streško
(5/2008, Events ) - ESMO KONGRES, ŠTOKHOLM, 12. – 16. 9. 2008, FIRST SLOVAKIAN EXPERIENCE
MUDr. Tomáš Šálek a kol.
(5/2008, Events ) - XLIII. bratislavských onkologických dní – správa z podujatia
MUDr. Oľga Szegheőová
(4/2006, Events ) - Dual inhibition after failure of NSAI as a solution to hormone therapy resistance
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2015, Review articles ) - Biological therapy in colorectal cancer
MUDr. Jozef Dolinský
(2/2011, Review articles ) - Antineoplastic treatment of patients with renal insufficency
MUDr. Ján Rajec, PhD., doc. MUDr. Michal Mego, PhD.
(2/2011, Review articles ) - SPRÁVA Z XLV. ROČNÍKA BRATISLAVSKÝCH ONKOLOGICKÝCH DNÍ, 1. – 3. OKTÓBER 2008
MUDr. Ľubica Švancárová
(6/2008, Events ) - Antiemetic therapy – what has brought the last decade?
MUDr. Jana Obertová
(6/2010, Review articles ) - Novinky z American Society of Clinical Oncology 2010
doc. MUDr. Peter Beržinec, CSc., MUDr. Tomáš Šálek, prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková
(4/2010, Events ) - Ribociclib, inhibitor of cyclin-dependent kinases 4 and 6, in the treatment of HR+/HER2 - advanced breast cancer
MUDr. Mária Rečková
(1/2017, Drugs & drug classes ) - The role of targeted therapy in the treatment of renal cell carcinoma
doc. MUDr. Jozef Mardiak, CSc.
(5/2009, Review articles ) - Temsirolimus – mTOR as a new target for the treatmet of advanced cell carcinoma (RCC) and relapsed and/or refractory mantle cell lymphoma (MCL)
doc. PharmDr. Juraj Sýkora, CSc.
(5/2009, Drugs & drug classes ) - Initial treatment of metastatic renal cell carcinoma
MUDr. Jana Obertová, PhD.
(1/2018, Main topic ) - Nivolumab in the renal cell carcinoma treatment
MUDr. Bc. Patrik Palacka, PhD., MPH, MBA, LL.M., Vladimíra Baranová
(1/2018, Main topic ) - Systemic treatment of metastatic renal cell carcinoma after failure of the first line of treatment
MUDr. Dagmar Sudeková
(1/2018, Main topic ) - TREATMENT OF ADULT MALIGNANT BRAIN TUMOURS
MUDr. Peter Kalina, CSc.
(3/2007, Review articles - treatment )